• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Using 3D models to reduce side effects of radiotherapy

Bioengineer by Bioengineer
March 14, 2019
in Chemistry
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Joe Vittorio

The debilitating side effects of radiotherapy could soon be a thing of the past thanks to a breakthrough by University of South Australia (UniSA) and Harvard University researchers.

UniSA biomedical engineer Professor Benjamin Thierry is leading an international study using organ-on-a-chip technology to develop 3D models to test the effects of different levels and types of radiation.

A microfluidic cell culture chip closely mimics the structure and function of small blood vessels within a disposable device the size of a glass slide, allowing researchers and clinicians to investigate the impact of radiotherapy on the body’s tissues.

To date, scientists have relied on testing radiotherapy on cells in a two-dimensional environment on a slide.

Professor Thierry, from UniSA’s Future Industries Institute (FII) and the ARC Centre of Excellence in Convergent Bio-Nano Science and Technology (CBNS), says the organ-on-a-chip technology could reduce the need for animal studies and irrelevant invitro work, both of which have major limitations.

“An important finding of the study is that endothelial cells grown in the standard 2D culture are significantly more radiosensitive than cells in the 3D vascular network. This is significant because we need to balance the effect of radiation on tumour tissues while preserving healthy ones,” Prof Thierry says.

The findings, published in Advanced Materials Technologies, will allow researchers to fully investigate how radiation impacts on blood vessels and – soon – all other sensitive organs.

“The human microvasculature (blood vessel systems within organs) is particularly sensitive to radiotherapy and the model used in this study could potentially lead to more effective therapies with fewer side effects for cancer patients,” Prof Thierry says.

More than half of all cancer patients receive radiotherapy at least once in the course of their treatment. While it cures many cancers, the side effects can be brutal and sometimes lead to acute organ failure and long-term cardiovascular disease.

Prof Thierry’s team, including UniSA FII colleague Dr Chih-Tsung Yang and PhD student Zhaobin Guo, are working in close collaboration with the Royal Adelaide Hospital and Harvard University’s Dana-Farber Cancer Institute with the support of the Australian National Fabrication Facility.

“Better understanding the effect of radiotherapy on blood vessels within organs – and more generally on healthy tissues – is important, especially where extremely high doses and types of radiation are used,” Dr Yang says.

The researchers’ next step is to develop body-on-chip models that mimic the key organs relevant to a specific cancer type.

###

Media contact: Professor Benjamin Thierry +618 8302 3689 mobile: +61 411 837 941 email: benjamin.thierry@unisa.edu.au; Candy Gibson UniSA media office +618 8302 0961
mobile: +61 434 605 142 email: candy.gibson@unisa.edu.au

Media Contact
Candy Gibson
candy.gibson@unisa.edu.au

Related Journal Article

http://dx.doi.org/10.1002/admt.201800726

Tags: BiochemistryBiomedical/Environmental/Chemical EngineeringBiotechnologycancerMedicine/HealthNanotechnology/Micromachines
Share12Tweet8Share2ShareShareShare2

Related Posts

Monascus Fermentation Enhances Bioactive Isoflavones and Antioxidant Activity in Soybean Leaves

Monascus Fermentation Enhances Bioactive Isoflavones and Antioxidant Activity in Soybean Leaves

November 18, 2026
Repeated Freezing and Thawing Drives Lipid Degradation in Tibetan Chicken Meat

Repeated Freezing and Thawing Drives Lipid Degradation in Tibetan Chicken Meat

November 18, 2026

Barium Titanate Preferentially Localizes in Epoxidized Rubber Blends with Tunable Properties

November 18, 2026

Novel MXene and Graphitic Carbon Nitride Heterostructures Efficiently Degrade Textile Dyes

November 18, 2026
Please login to join discussion

POPULAR NEWS

  • Electroacupuncture Mobilizes Unique CD34-Positive Stem-Like Cells in Healthy Dogs

    Electroacupuncture Mobilizes Unique CD34-Positive Stem-Like Cells in Healthy Dogs

    29 shares
    Share 12 Tweet 7
  • Specialists Outline Cervical Cancer Screening Principles for Resource-Limited Settings

    29 shares
    Share 12 Tweet 7
  • Modified Halpern Proximal Algorithm Solves Multi-Structured Problems in Curved Hadamard Spaces

    29 shares
    Share 12 Tweet 7
  • Machine Learning Outperforms Pharmacokinetic Models Predicting Initial Vancomycin Concentrations in Septic Patients

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Surgeons Perform Hybrid Thoracoscopic and Endoscopic Enucleation for Rare Esophageal Foregut Cyst

Vine Tea Transcriptome Analysis Identifies Key Regulators of High Dihydromyricetin Biosynthesis

Carbapenem-Resistant Klebsiella Infections Surge 72 Percent Across Europe Since 2019

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.